Research Report on Cancer Vaccines Market Outlines Growth Opportunities & Industry Status

Big Market Research added a report on “Cancer Vaccines Market By Technology (Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Whole Cell Cancer Vaccines, And Viral Vector & DNA Cancer Vaccines), Type (Preventive Cancer Vaccines And Therapeutic Cancer Vaccines), Indication (Cervical Cancer, Prostate Cancer, And Others), And End Use (Pediatrics And Adults) – Global Opportunity Analysis And Industry Forecast, 2017-2023”

A vaccine market is a biological preparation that strengthens the immune system and provides acquired immunity against a specific pathogen. According to the World Health Organization (WHO), cancer vaccines are popularly for treating various types of cancer such as, breast cancer, lung cancer, cervical cancer, and others. The key factors that driving the market growth include rise in prevalence of human papilloma virus (HPV) infections leading to cancers, increase in administration of prophylactic cancer vaccines, surge in investments in the development of cancer vaccines by manufacturers & governmental funding, and launch & approval of novel cancer vaccines in the market. The global cancer vaccines market was valued at $4,073 million in 2016, and is expected to reach at $12,814 million by 2023, registering a CAGR of 17.7% from 2017 to 2023.

Request for Sample Copy@

The global cancer vaccines market is segmented based on technology, indication, type end use, and region. Based on technology, it is categorized into dendritic cells (DC) cancer vaccines, recombinant cancer vaccines, antigen/adjuvant cancer vaccines, whole cell cancer vaccines, and viral vector & DNA cancer vaccines. Based on indication, it is bifurcated into cervical cancer, prostate cancer, and others. On the basis of end use, it is classified into  pediatric vaccines and adult vaccines. Based on type, the market is divided into therapeutic cancer vaccines and preventive cancer vaccines.

Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the highest market share in 2016, and is expected to maintain its dominance throughout the forecast period. This is attributed to the increase in prevalence of cervical cancers, rise in government focus on immunization programs, emergence of new vaccines, and growth in technological advancements in vaccine administration. However, Asia-Pacific is expected to witness maximum growth potential, due to the improvement in healthcare facilities, high disposable income, and rapid development of economic conditions.

For Purchase Enquiry@

Key Benefits

  • The study provides an in-depth analysis of the global cancer vaccines market with current trends and future estimations to elucidate the imminent investment pockets.
  • Comprehensive analysis of factors that drive and restrict the market growth is provided in the report.
  • Comprehensive quantitative analysis of the industry from 2016 to 2023 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the key segments of the industry to understand the type of products and technologies used globally.
  • Key market players and their strategies are provided to understand the competitive outlook of the market.


By Technology

  • Dendritic Cells (DC) Cancer Vaccines
  • Recombinant Cancer Vaccines
  • Antigen/Adjuvant Cancer Vaccines
  • Whole Cell Cancer Vaccines
  • Viral Vector & DNA Cancer Vaccines

By Type

  • Preventive Cancer Vaccines
  • Therapeutic Cancer Vaccines

By Indication

  • Cervical Cancer
  • Prostate Cancer
  • Others

By End Use

  • Pediatrics
  • Adults

By Geography

  • North America
  • Europe
  • Asia-Pacific

Contact Us:

5933 NE Win Sivers Drive,

#205, Portland, OR 97220, United States

Direct: + 1-503-894-6022

Toll Free:  + 1-800-910-6452



Designed by
Powered by
%d bloggers like this: